|
2025
|
Invention
|
Clascoterone formulations and methods of use thereof. The present disclosure is related to a topi... |
|
|
Invention
|
Clascoterone and minoxidil combination therapy for use in treating hair loss. The present disclos... |
|
|
G/S
|
Non-medicated cosmetics for the care and treatment of the skin; cosmetics; non-medicated cosmetic... |
|
|
Invention
|
Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivat... |
|
|
Invention
|
Pyrilutamide combination therapy. The present disclosure provides a method of treating hair loss ... |
|
2024
|
Invention
|
Cortexolone-17αlpha-propionate combinations for treating acne. The present disclosure relates to ... |
|
|
Invention
|
Cortexolone-17α-propionate for treating acneiform eruptions. The present disclosure provides a me... |
|
|
G/S
|
Cosmetic skin care and treatment preparations; cosmetic
products; dermatological creams [other t... |
|
2023
|
Invention
|
High concentration formulation.
The present disclosure provides high concentration formulations ... |
|
2022
|
G/S
|
Cosmetic preparations for skin care and skin treatment; cosmetics; dermatological creams, namely,... |
|
|
G/S
|
Non-medicated cosmetics for the care and treatment of the skin; cosmetics; non-medicated dermatol... |
|
|
G/S
|
Cosmetic skin care and treatment preparations; Cosmetic products; Dermatological creams [other th... |
|
2021
|
Invention
|
High concentration formulation. The present disclosure provides high concentration formulations o... |
|
2019
|
Invention
|
Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives... |
|
2017
|
Invention
|
Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds. ... |
|
2016
|
Invention
|
High concentration formulation of cortexolone-17a-propionate for treating alopecia. The present d... |
|
2015
|
Invention
|
Topical formulations of tellurium-containing compounds. Novel formulations of tellurium-containin... |
|
|
Invention
|
17alpha, 21-dihydroxypregnene esters as antiandrogenic agents. The present application provides 1... |
|
|
G/S
|
Cosmetic; dermo-cosmetic products for the person aimed at the preservation of the beauty and heal... |
|
|
G/S
|
Cosmetic skin care and treatment preparations; Cosmetic products; Cosmetic preparations for care ... |
|
|
G/S
|
Cosmetic for the care and treatment of the skin namely milk for cosmetic purposes, aloe vera gel ... |
|
|
G/S
|
Cosmetic preparations for the care and treatment of the skin namely milk for cosmetic purposes, a... |
|
|
G/S
|
non-medicated cosmetics for the care and treatment of the skin; cosmetics; non-medicated dermatol... |
|
2014
|
Invention
|
Cortexolone 17α-propionate for use in the treatment of skin wounds and/or atrophic skin disorders... |
|
|
Invention
|
17 alpha, 21-dihydroxypregnene esters as antiandrogenic agents. 17α,21-Dihydroxypregna-4,9(11)-di... |
|
|
Invention
|
Use of tellurium compounds for the treatment actinic keratosis.
Methods for treating skin condit... |
|
2013
|
Invention
|
17alfa, 21-dihydroxypregnene esters as antiandrogenic agents. 17α,21-Dihydroxypregna-4,9(11)-dien... |
|
|
Invention
|
Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives.... |
|
2010
|
Invention
|
Use of tellurium compounds for inhibition of interleukin-converting enzyme. Use of tellurium-cont... |
|
2009
|
Invention
|
17α, 21-dihydroxypregnene esters as antiandrogenic agents. 17α,21-Dihydroxypregna-4,9-diene-3,20-... |
|
2006
|
Invention
|
Use of tellurium compounds for the treatment of actinic keratosis. Methods for treating skin cond... |
|
2002
|
Invention
|
17alfa, 21-dihydroxypregnene esters as antiandrogenic agents.
17.alpha.,21-Dihydroxypr... |
|
2001
|
Invention
|
Method of treating psoriasis. The invention comprises the administration of an effective amount o... |
